Harnessing the potential of ginger/derivatives as therapeutic targets in the management of knee osteoarthritis: a molecular docking approach
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20260428Keywords:
Musculoskeletal diseases, Knee osteoarthritis, Zinger derivatives, 6-Gingerol, 8- Gingerol, Inflammation, TNF-α - IL-1β and inflammasome NLRP3Abstract
Background: Amongst musculoskeletal diseases, knee osteoarthritis (KOA) form most critical chronic joint disorder being more prevalent in females than in males, increases markedly in elderly population and correlate significantly with obesity. The structural alterations underlining KOA includes cartilage degradation, subchondral bone lesion, osteophyte formation, and altered changes in synovium and joints capsule.Inflammation forms core player of KOA to set in progressive and degenerative changes of knee joints vis-a-vis up regulate battery of pro-inflammatory cytokines including (TNF-α,IL-1β) as well as inflammasome complex(NLRP3).We hypothesize that ginger/its derivatives which have been well documented for their culinary and anti-inflammatory functions would be effective as anti-inflammatory in KOA to protect the joint degeneration.
Methods: In the present study we selected 15 ginger derivatives (literature survey) and with molecular docking approach screened the derivatives targeted against potent key inflammatory markers of KOA including TNF-α, IL-1β and inflammasome NLRP3complex. Subsequently we scored for highest binding energy and lowest binding distance (HBE-LBD) using Schrödinger software.
Results: Interestingly, we show that 6-gingerol and Zingerone demonstrated highest HBE-LBD for TNF-α,6-gingerol and paradol for IL-1β, and 8-gingerol and 10-gingerol for NLRP3 receptor.
Conclusions: Our findings are novel and report for the first time for the differential cross talk of ginger derivatives for a given Ligand displaying higher binding affinity and specificity to inflammatory targets. Way forward, we advocate carrying out efficacy studies using combinational approach 6-gingerol/Zingerone/paradol vis-à-vis 8-gingerol and 10-gingerol in KOA model to unravel target precision of the identified ginger derivatives so as to arrive for their therapeutic signatures in management of KOA.
Metrics
References
Gill TK, Mittinty MM, March LM, Steinmetz JD, Culbreth GT, Cross M, et al. Global, regional, and national burden of other musculoskeletal disorders, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. The Lancet Rheumatol. 2023;5(11):e670-82.
Lv Y, Sui L, Lv H, Zheng J, Feng H, Jing F. Burden of knee osteoarthritis in China and globally from 1992 to 2021, and projections to 2030: a systematic analysis from the Global Burden of Disease Study 2021. Front Public Health. 2025;13:1543180. DOI: https://doi.org/10.3389/fpubh.2025.1543180
Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. The lancet. 2020;396(10258):1204-22. DOI: https://doi.org/10.1016/S0140-6736(20)30925-9
Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage. 2013;21(1):16-21. DOI: https://doi.org/10.1016/j.joca.2012.11.012
Scanzello CR. Role of low-grade inflammation in osteoarthritis. Curr Opin Rheumatol. 2017;29(1):79-85. DOI: https://doi.org/10.1097/BOR.0000000000000353
McAllister MJ, Chemaly M, Eakin AJ, Gibson DS, McGilligan VE. NLRP3 as a potentially novel biomarker for the management of osteoarthritis. Osteoarthritis Cartilage. 2018;26(5):612-9. DOI: https://doi.org/10.1016/j.joca.2018.02.901
Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477-89. DOI: https://doi.org/10.1038/s41577-019-0165-0
Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 Inflammasome: An overview of mechanisms of activation and regulation. Int J Mol Sci. 2019;20(13):3328. DOI: https://doi.org/10.3390/ijms20133328
Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011;7(1):33-42. DOI: https://doi.org/10.1038/nrrheum.2010.196
Raju SS, Niranjan T, Pandiyan P, Snehitha MS. A review of an early detection and quantification of osteoarthritis severity in knee using machine learning techniques. InIOP conference series: materials science and engineering. 2021;1057(1):012095. DOI: https://doi.org/10.1088/1757-899X/1057/1/012095
Liu YR, Wang JQ, Li J. Role of NLRP3 in the pathogenesis and treatment of gout arthritis. Front Immunol. 2023;14:1137822. DOI: https://doi.org/10.3389/fimmu.2023.1137822
Kitagawa T, Isaji Y, Sasaki D, Onishi K, Hayashi M, Okuyama W. Effectiveness of exercise therapy in patients with knee osteoarthritis: an overview of systematic reviews. BMJ open. 2025;15(7):e093163. DOI: https://doi.org/10.1136/bmjopen-2024-093163
Carr AJ, Robertsson O, Graves S, Price AJ, Arden NK, Judge A, et al. Knee replacement. Lancet. 2012;379(9823):1331-40. DOI: https://doi.org/10.1016/S0140-6736(11)60752-6
Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal anti -inflammatory drugs. N Engl J Med. 1999;340(24):1888-99. DOI: https://doi.org/10.1056/NEJM199906173402407
Semwal RB, Semwal DK, Combrinck S, Viljoen AM. Gingerols and shogaols: important nutraceutical principles from Zingiber officinale. Phytochemistry. 2015;117:554-68. DOI: https://doi.org/10.1016/j.phytochem.2015.07.012
Frondoza CG, Sohrabi A, Polotsky A, Phan PV, Hungerford DS, Lindmark L. An in vitro screening assay for inhibitors of proinflammatory mediators in herbal extracts using human synoviocyte cultures. In Vitro Cellular & Developmental Biology-Animal. 2004;40(3):95-101. DOI: https://doi.org/10.1290/1543-706X(2004)040<0095:AIVSAF>2.0.CO;2
Ruangsuriya J, Budprom P, Viriyakhasem N, Kongdang P, Chokchaitaweesuk C, Sirikaew N, et al. Suppression of Cartilage Degradation by Zingerone Involving the p38 and JNK MAPK Signaling Pathway. Planta Med. 2017;83(4):268-76. DOI: https://doi.org/10.1055/s-0042-113387
Shen CL, Smith BJ, Lo DF, Chyu MC, Dunn DM, Chen CH, et al. Dietary supplementation with ginger root attenuates knee osteoarthritis in a rat model: role of MMPs and cytokines. J Med Food. 2012;15(6):545-52.
Grzanna R, Lindmark L, Frondoza CG. Ginger-an herbal medicinal product with broad anti-inflammatory actions. J Med Food. 2005;8(2):125-32. DOI: https://doi.org/10.1089/jmf.2005.8.125
Mozaffari-Khosravi H, Naderi Z, Dehghan A, Nadjarzadeh A, Fallah Huseini H. Effect of ginger supplementation on proinflammatory cytokines in patients with knee osteoarthritis: a randomized controlled trial. J Nutr Gerontol Geriatr. 2016;35(3):209-18. DOI: https://doi.org/10.1080/21551197.2016.1206762
Naismith JH, Devine TQ, Kohno T, Sprang SR. Structures of the extracellular domain of the type I tumor necrosis factor receptor. Structure. 1996;4(11):1251-62. DOI: https://doi.org/10.1016/S0969-2126(96)00134-7
Priestle JP, Schär HP, Grütter MG. Crystallographic refinement of interleukin 1 beta at 2.0 A resolution. Proc Natl Acad Sci. 1989;86(24):9667-71. DOI: https://doi.org/10.1073/pnas.86.24.9667
Dekker C, Mattes H, Wright M, Boettcher A, Hinniger A, Hughes N, et al. Crystal structure of NLRP3 NACHT domain with an inhibitor defines mechanism of inflammasome inhibition. J Mol Biol. 2021;433(24):167309. DOI: https://doi.org/10.1016/j.jmb.2021.167309
Kundur S, Perugu S. Quantification of total phenols in Coleus forskohlii and inhibition of aldose reductase by rosmarinic acid. Journal of Molecular Structure. 2024;1312:138435. DOI: https://doi.org/10.1016/j.molstruc.2024.138435
Kotikalapudi N, Sampath SJ, Sukesh Narayan S, Ramesh R B, Nemani H, Mungamuri SK, et al. The promise (s) of Mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems. Sci rep. 2021;11(1): 16983. DOI: https://doi.org/10.1038/s41598-021-96121-0
Sampath SJP, Rath SN, Kotikalapudi N, Vijayalakshmi V. Beneficial effects of secretome derived from mesenchymal stem cells with stigmasterol to negate IL-1β-induced inflammation in-vitro using rat chondrocytes—OA management. Inflammopharmacology. 2021;29(6):1701-17. DOI: https://doi.org/10.1007/s10787-021-00874-z
Nanchari SR, Perugu S, Venkatesan V. Molecular docking studies to understand the potential role of ginger compounds (6-gingeroland 6-shogaol) on anti-angiogenic and anti-lymphangiogenic mechanisms. International Journal of Chemistry. 2020;12(1):61-8. DOI: https://doi.org/10.5539/ijc.v12n1p61
Tripathi S, Maier KG, Bruch D, Kittur DS. Effect of 6-gingerol on pro-inflammatory cytokine production and costimulatory molecule expression in murine peritoneal macrophages. J Surg Res. 2007 ;138(2):209-13. DOI: https://doi.org/10.1016/j.jss.2006.07.051
Sampath SJ, Birineni S, Perugu S, Kotikalapudi N, Venkatesan V. Therapeutic efficacy of 6-gingerol and 6-shogaol in promoting browning of white adipocytes vis-à-vis enhanced thermogenesis portrayed in high fat milieu. Food Bioscience. 2021;42:101211. DOI: https://doi.org/10.1016/j.fbio.2021.101211
Su CC, Wang SC, Chen IC, Chiu FY, Liu PL, Huang CH, et al. Zerumbone suppresses the LPS-induced inflammatory response and represses activation of the NLRP3 inflammasome in macrophages. Frontiers in Pharmacology. 2021 May 11;12:652860.
Lee TY, Lee KC, Chen SY, Chang HH. 6-Gingerol inhibits ROS and iNOS through the suppression of PKC-α and NF-κB pathways in lipopolysaccharide-stimulated mouse macrophages. Biochem Biophys Res Commun. 2009;382(1):134-9. DOI: https://doi.org/10.1016/j.bbrc.2009.02.160
Robbins GR, Wen H, Ting JP. Inflammasomes and metabolic disorders: old genes in modern diseases. Molecular cell. 2014;54(2):297-308. DOI: https://doi.org/10.1016/j.molcel.2014.03.029
Han JH. Immuno-metabolic diseases and therapeutics: molecular mechanisms via inflammasome signaling. Cell Communication and Signaling. 2025;23(1):373. DOI: https://doi.org/10.1186/s12964-025-02368-9
Xu W, Huang Y, Zhou R. NLRP3 inflammasome in neuroinflammation and central nervous system diseases. Cell Mol Immunol. 2025;22:341-55. DOI: https://doi.org/10.1038/s41423-025-01275-w
Rafeeq M, Murad HAS, Abdallah HM, El-Halawany AM. Protective effect of 6-paradol in acetic acid-induced ulcerative colitis in rats. BMC Complement Med Ther. 2021;21(1):28. DOI: https://doi.org/10.1186/s12906-021-03203-7
Mao QQ, Xu XY, Cao SY, Gan RY, Corke H, Beta T, et al. Bioactive compounds and bioactivities of ginger (Zingiber officinale Roscoe). Foods. 2019;8(6):185. DOI: https://doi.org/10.3390/foods8060185
Ho SC, Chang YH. Comparison of inhibitory capacities of 6-, 8- and 10-gingerols/shogaols on the canonical NLRP3 inflammasome-mediated IL-1β secretion. Molecules. 2018;23(2):466. DOI: https://doi.org/10.3390/molecules23020466
Su CC, Wang SC, Chen IC, Chiu FY, Liu PL, Huang CH, et al. Zerumbone suppresses the LPS-induced inflammatory response and represses activation of the NLRP3 inflammasome in macrophages. Frontiers Pharmacol. 2021;12:652860. DOI: https://doi.org/10.3389/fphar.2021.652860
Lin J, Fang Y, Cao Y, Ma L, Tao M, Wang X, et al. Zerumbone attenuates the excessive proliferation of keratinocytes in psoriasis mice through regulating NLRP3/NF-κB pathway. Toxicol Res. 2023 ;12(4):658-64. DOI: https://doi.org/10.1093/toxres/tfad056
Dugasani S, Pichika MR, Nadarajah VD, Balijepalli MK, Tandra S, Korlakunta JN. Comparative antioxidant and anti-inflammatory effects of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol. J Ethnopharmacol. 2010;127(2):515-20. DOI: https://doi.org/10.1016/j.jep.2009.10.004
Downloads
Published
How to Cite
Issue
Section
